Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63679 | 1.00 | PTGS1 (0.39) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL2403909 | 1.00 | — | — | |
| SCHEMBL14414885 | 1.00 | PTGS1 (0.39) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL11343102 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL9897194 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL25336178 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL8463674 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Ammonia Solution, Strong SCHEMBL9351921 | 0.97 | PTGS1 (0.38) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Hydrazine SCHEMBL11671403 | 0.95 | LMNA (0.42) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Water SCHEMBL15641760 | 0.95 | PTGS1 (0.36) | PTGS1PDE4ALMNASLC6A6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10786602-B2 | Method for treating surface of implant | OSSTEMIMPLANT CO., LTD. (KR) | 2020-09-29 | — | — | US | claimed |
| EP-2992908-A1 | METHOD FOR TREATING SURFACE OF IMPLANT | Osstemimplant Co., Ltd. (KR) | 2016-03-09 | — | — | EP | claimed |
| US-20160058920-A1 | Method for Treating Surface of Implant | OSSTEMIMPLANT CO., LTD. (KR) | 2016-03-03 | — | — | US | claimed |
| WO-2022106611-A1 | NOVEL COMPOSITIONS OF BETA-LACTAM COMPOUNDS | XELLIA PHARMACEUTICALS APS (DK) | 2022-05-27 | — | — | WO | disclosed |
| US-10786602-B2 | Method for treating surface of implant | OSSTEMIMPLANT CO., LTD. (KR) | 2020-09-29 | — | — | US | disclosed |
| EP-2992908-B1 | METHOD FOR TREATING SURFACE OF IMPLANT | OSSTEM IMPLANT CO LTD (KR) | 2020-09-02 | — | — | EP | disclosed |
| EP-2562776-B1 | INDUCTOR COMPOSED OF CAPACITOR ARRAY | NAT INST MATERIALS SCIENCE (JP) | 2019-07-31 | — | — | EP | disclosed |
| EP-2992908-A1 | METHOD FOR TREATING SURFACE OF IMPLANT | Osstemimplant Co., Ltd. (KR) | 2016-03-09 | — | — | EP | disclosed |
| US-20160058920-A1 | Method for Treating Surface of Implant | OSSTEMIMPLANT CO., LTD. (KR) | 2016-03-03 | — | — | US | disclosed |
| EP-2635553-A1 | STABILIZATION OF OZONE-LABILE FLUORESCENT DYES BY THIOUREA | Ibis Biosciences, Inc. (US) | 2013-09-11 | — | — | EP | disclosed |
| US-20130106538-A1 | INDUCTOR COMPRISING ARRAYED CAPACITORS | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2013-05-02 | — | — | US | disclosed |
| EP-2562776-A1 | INDUCTOR COMPOSED OF CAPACITOR ARRAY | National Institute for Materials Science (JP) | 2013-02-27 | — | — | EP | disclosed |
| WO-2012037394-A1 | STABILIZATION OF OZONE-LABILE FLUORESCENT DYES BY THIOUREA | IBIS BIOSCIENCES, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| US-20080312161-A1 | Compounds For Stabilizing Factor VII Polypeptide Formulations | NOVO NORDISK HEALTH CARE AG (CH) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312161-A1 | Compounds For Stabilizing Factor VII Polypeptide Formulations | F7, F5, F13B | PTGS1 3210/4885PDE4A 3007/4885LMNA 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.